Clinical Trials Browser

Phase 2 × Cholangiocarcinoma × zimberelimab × Clear all

NCT06048133 2026-01-23

Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

Phase 2 Recruiting

Gastrointestinal

Bile Duct Neoplasms, Cholangiocarcinoma

NCT05724563 2025-05-21

Domvanalimab and Zimberelimab in Advanced Liver Cancers

Phase 2 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Cholangiocarcinoma